Drug discovery is changing—and collaboration is driving what comes next.

The opening session of the 2026 Michigan Drug Discovery & Development Symposium sets the stage for a day of insight, innovation, and connection across Michigan’s life sciences ecosystem.

This session brings together industry leaders to explore how drug discovery is being reimagined in response to rapid scientific, technological, and market shifts. Panelists will examine the forces reshaping traditional models—including breakthroughs in digital and data-driven innovation, new frameworks for cross-sector collaboration, regulatory recalibration, and changing business strategies.

Discussion will center on how these drivers are converging to transform the way therapies are discovered, developed, and delivered – accelerating the journey from early research to patient impact.